George Church praised the Nobel committee’s choice and noted that there are plenty of ideas and companies to go around [1]. I wouldn’t be surprised if CRISPR in medical applications leads to future Nobel prizes, and there will be many winners on the commercial side (e.g. Editas cofounded by Church, Doudna, Zhang and others [2]).